Abstract: A technology for detecting fetal movement. In one example an electrocardiogram (ECG) dataset can be obtained where the ECG dataset contains fetal heart rate (FHR) values acquired from a pregnant subject, and the ECG dataset is for a segment of time during which an FHR is monitored using an ECG monitor. An FHR baseline can be calculated for the FHR values in the ECG dataset, and the ECG dataset can be analyzed to identify an accelerated FHR value that exceeds the FHR baseline that is followed in time in the ECG dataset by a decelerated FHR value that is less than or equal to the FHR baseline. Identifying the accelerated FHR value followed in time in the ECG dataset by the decelerated FHR value in the ECG dataset may indicate a fetal movement.

Abstract: A jersey shirt having a frontal appearance of a dress shirt and a back appearance of a sports jersey. The jersey shirt may be a unitary garment or have separable garment components. The jersey shirt provides a formal dress shirt frontal appearance when worn with a jacket and provides a sports jersey appearance on the back of the shirt when the jacket is removed.

Abstract: A method, apparatus, and a system for providing data representation associated with non-sampled workpieces. Measured metrology data relating to a first workpiece is received. Metrology data corresponding to a second workpiece is approximated based upon the metrology data relating to the first workpiece to provide a projected metrology data relating to the second workpiece.

Abstract: An inducible or regulatable retroviral vector for the controlled delivery of a gene product, and in particular, a tetracycline regulated retroviral vector for the controlled delivery of a gene product is disclosed. This retroviral vector contains the following DNA sequences operatively linked from 5' to 3': (a) DNA comprising a first promoter; (b) DNA comprising a second promoter different from the first promoter in (a) and different from the third promoter in (e); (c) DNA encoding a tetracycline regulator unit (tTA) under the transcriptional control of the second promoter; (d) DNA comprising a tetracycline response unit (tetO) in an antisense orientation relative to the DNA encoding the regulator unit of (c); and (e) DNA comprising a third promoter different from the first promoter in (a) and different from the second promoter in (b) wherein the DNA comprising the response unit (d) is comprised within the third promoter.